A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The Swiss partners in the consortium were funded by Innosuisse.
Guidelines: Safe-by-design for medicinal polymeric nanocarriers
Related articles
Guidelines: Safe-by-desig...
A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Need help with the regist...
eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
Crucial results for coron...
Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Subscribe to our newslett...
Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Microplastics and Nanopla...
Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Medical Device Regulation...
Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
CLINAM
25.-28.10.20, 12th European and Global CLINAM‐Summit, Basel, Programme
Pigments are Nano
A webinar by contactpointnano.ch Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented